Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)
… In the SUSTAIN-6 study, involving patients with T2D with high cardiovascular risk, a 26% statistically significant risk reduction of major cardiovascular events was documented for OW …..... Read More